Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification

A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics

(2017) Martin J. van den Bent et al.   NEURO-ONCOLOGY

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision

(2017) Takashi KOMORI   NEUROLOGIA MEDICO-CHIRURGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

A comprehensive analysis identifies BRAF hotspot mutations associated with gliomas with peculiar epithelial morphology

(2016) Ryusuke Hatae et al.   NEUROPATHOLOGY

Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade

(2016) Nobuhiro Hata et al.   OncoTargets and Therapy

Precise Detection of IDH1/2 and BRAF Hotspot Mutations in Clinical Glioma Tissues by a Differential Calculus Analysis of High-Resolution Melting Data

(2016) Ryusuke Hatae et al.   PLoS One

Mutational landscape and clonal architecture in grade II and III gliomas

(2015) Hiromichi Suzuki et al.   NATURE GENETICS

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

(2015) Jeanette E. Eckel-Passow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

(2012) Gregory Cairncross et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

(2012) Martin J. van den Bent et al.   JOURNAL OF CLINICAL ONCOLOGY

Loss of heterozygosity analysis in malignant gliomas

(2011) Masahiro Mizoguchi et al.   Brain Tumor Pathology

Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses†

(2010) Artemis P. Vogazianou et al.   NEURO-ONCOLOGY

Polysomy for Chromosomes 1 and 19 Predicts Earlier Recurrence in Anaplastic Oligodendrogliomas with Concurrent 1p/19q Loss

(2009) M. Snuderl et al.   CLINICAL CANCER RESEARCH

NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide

(2009) Wolfgang Wick et al.   JOURNAL OF CLINICAL ONCOLOGY

Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues

(2008) Daisuke Kuga et al.   NEURO-ONCOLOGY